These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11421288)

  • 21. Vero cytotoxin binding to polymorphonuclear leukocytes among households with children with hemolytic uremic syndrome.
    te Loo DM; Heuvelink AE; de Boer E; Nauta J; van der Walle J; Schröder C; van Hinsbergh VW; Chart H; van de Kar NC; van den Heuvel LP
    J Infect Dis; 2001 Aug; 184(4):446-50. PubMed ID: 11471102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes.
    Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA
    Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress.
    Moritz MW; Reimers RC; Baker RK; Sutera SP; Joist JH
    J Lab Clin Med; 1983 Apr; 101(4):537-44. PubMed ID: 6833826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation.
    Viisoreanu D; Gear A
    Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
    Ståhl AL; Sartz L; Karpman D
    Blood; 2011 May; 117(20):5503-13. PubMed ID: 21447825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of binding and effects of Escherichia coli Shiga toxin 1 on bovine and ovine granulocytes.
    Menge C; Eisenberg T; Stamm I; Baljer G
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):392-403. PubMed ID: 16884782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function.
    Guessous F; Marcinkiewicz M; Polanowska-Grabowska R; Keepers TR; Obrig T; Gear AR
    Thromb Haemost; 2005 Nov; 94(5):1019-27. PubMed ID: 16366002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced platelet aggregation in hemolytic-uremic syndrome.
    Kaplan BS; Fong JS
    Thromb Haemost; 1980 Jun; 43(2):154-7. PubMed ID: 7455975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981).
    Fox SC; Judge HM; Allen BR; Heptinstall S
    Platelets; 2002 Jun; 13(4):213-8. PubMed ID: 12189022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.
    Cooling LL; Walker KE; Gille T; Koerner TA
    Infect Immun; 1998 Sep; 66(9):4355-66. PubMed ID: 9712788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-step method for purification of Shiga toxin-1 B subunit using receptor-mediated affinity chromatography by globotriaosylceramide-conjugated octyl sepharose CL-4B.
    Nakajima H; Katagiri YU; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Mimori K; Saito M; Nakao H; Takeda T; Fujimoto J
    Protein Expr Purif; 2001 Jul; 22(2):267-75. PubMed ID: 11437603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome.
    Clayton F; Pysher TJ; Lou R; Kohan DE; Denkers ND; Tesh VL; Taylor FB; Siegler RL
    Am J Nephrol; 2005; 25(6):536-40. PubMed ID: 16179829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotypes and virulence markers of Shiga toxin-producing Escherichia coli (STEC) isolated from dairy cattle in São Paulo State, Brazil.
    Irino K; Kato MA; Vaz TM; Ramos II; Souza MA; Cruz AS; Gomes TA; Vieira MA; Guth BE
    Vet Microbiol; 2005 Jan; 105(1):29-36. PubMed ID: 15607081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate.
    Li M; Wu WK; Liu L; Liao FL; Shinohara Y; Handa S; Goto S
    Chin Med J (Engl); 2004 Feb; 117(2):241-6. PubMed ID: 14975210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced laboratory-based surveillance of Shiga-toxin-producing Escherichia coli O157 in The Netherlands.
    Van Duynhoven YT; De Jager CM; Heuvelink AE; Van Der Zwaluw WK; Maas HM; Van Pelt W; Wannet WJ
    Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):513-22. PubMed ID: 12172742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.